Lung Cancer: Radiotherapy

Department of Health and Social Care written question – answered on 3rd September 2019.

Alert me about debates like this

Photo of Tim Farron Tim Farron Liberal Democrat Lords Spokesperson (Communities and Local Government), Liberal Democrat Spokesperson (Work and Pensions), Liberal Democrat Spokesperson (Housing, Communities and Local Government), Liberal Democrat Spokesperson (North of England) (Northern Powerhouse)

To ask the Secretary of State for Health and Social Care, which clinical trials are currently being monitored by NHS England’s national specialised commissioning team to assess the evidence base for the use of Stereotactic Ablative Radiotherapy to treat early non-small cell lung cancer.

Photo of Jo Churchill Jo Churchill The Parliamentary Under-Secretary for Health and Social Care

NHS England has routinely commissioned stereotactic ablative radiotherapy to treat early non-small cell lung cancer since 2013, meaning that the evidence to support its routine commissioning has already been established for patients that meet the eligibility criteria described in the clinical commissioning policy. NHS England has since reviewed the clinical evidence for later stage non-small cell lung cancer and all stages of small cell lung cancer and a second policy is in development.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.